Distinguishing Urothelial Carcinoma in the Upper Urinary Tract from Benign Diseases with Hematuria Using FISH.

Jiandong Wang,Jinrong Wu,Libo Peng,Pin Tu,Wanchun Li,Leilei Liu,Wen Cheng,Xuan Wang,Shuigen Zhou,Shanshan Shi,Henghui Ma,Guangming Lu,Xiaojun Zhou
DOI: https://doi.org/10.1159/000341622
2012-01-01
Acta Cytologica
Abstract:OBJECTIVE:The aims of this study were to evaluate the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasive molecular test to distinguish urothelial carcinoma (UC) in the upper urinary tract (UUT) from benign lesions presenting with hematuria.STUDY DESIGN:The chromosomal abnormalities of chromosomes 3, 7, 17 and 9 (p16) in hematuria specimens from 34 patients with UUT-UC and 33 patients with benign disorders were detected using a set of fluorescently labeled DNA probes. The abnormalities of the chromosomes were determined and analyzed between UUT-UC and benign disorders.RESULTS:Chromosomal abnormalities were detected in 25 of 34 (73.5%) patients with UUT-UC and in 2 of 33 (6.1%) patients with benign disorders (p < 0.001).CONCLUSIONS:FISH of chromosomes 3, 7, 9 and 17 performed on exfoliated cells from voided urine specimens may serve as a non-invasive tool to distinguish UUT-UC from benign disorders presenting with hematuria.
What problem does this paper attempt to address?